{"id":"W4394014497","doi":"10.1161/circulationaha.124.069217","title":"Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial","year":2024,"lang":"en","type":"article","venue":"Circulation","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Manitoba; University of Toronto; Toronto General Hospital; University Health Network; Canadian VIGOUR Centre; University of Alberta; Women's College Hospital","funders":"HLS Therapeutics; Idorsia Pharmaceuticals; Novo Nordisk; Eisai; Moderna; MyoKardia; Amarin Corporation; Regeneron Pharmaceuticals; Boston Scientific Corporation; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; CSL Behring; Alnylam Pharmaceuticals; Sanofi; Amgen; Pfizer; Ironwood Pharmaceuticals, Incorporated","keywords":"Medicine; Empagliflozin; Myocardial infarction; Cardiology; Heart failure; Internal medicine; Clinical trial; Diabetes mellitus; Type 2 diabetes","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001225908,0.0001316092,0.0002463488,0.00008710052,0.00003356585,0.0000432931,0.00003253986,0.0000687182,0.0001139967],"category_scores_gemma":[0.00003656933,0.00007551592,0.0002345434,0.0001426081,0.00002625901,0.0001027635,0.00001712141,0.00009471335,0.0001390463],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006703543,"about_ca_system_score_gemma":0.00002054617,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001984252,"about_ca_topic_score_gemma":0.000005333462,"domain_scores_codex":[0.9991649,0.0001005852,0.0001722652,0.000190349,0.0002743502,0.00009749409],"domain_scores_gemma":[0.999378,0.0002758264,0.00003087847,0.000257905,0.00001919286,0.00003824236],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02870313,0.0004342901,0.8883621,0.0003087629,0.008979056,0.00009357493,0.004118604,0.0001769487,0.005049332,0.001175659,0.02632324,0.03627538],"study_design_scores_gemma":[0.01430953,0.001194793,0.9678155,0.0001939805,0.002051291,0.000001088415,0.000028733,0.0002812038,0.001465974,0.000256512,0.01228426,0.0001171126],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9940717,0.0002021865,0.00003512731,0.003098728,0.0009995868,0.0009521645,0.00001198065,0.0000747581,0.0005537883],"genre_scores_gemma":[0.9987096,0.000005218839,0.00001759574,0.0003884042,0.0005319639,0.0001051003,0.0001278293,0.0000160397,0.00009825568],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07945351,"threshold_uncertainty_score":0.307945,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009270853414509537,"score_gpt":0.272623657704443,"score_spread":0.2633528042899334,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}